TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Lanza Mucosal Injury Score of the stomach
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Dynamic gait index (DGI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of days alive and free from mechanical ventilation
Endpoint domain: Mortality/survival
Primary endpoint: Activities-Specific Balance Confidence Scale (A-ABC scale)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Dizziness handicap inventory questionnaire (A-DHI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Katz Index of Independence in Activities of Daily Living (Katz ADL)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in Gingival tissue thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rectal bulge size and classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mercuri Scores of upper limbs, trunk, and lower limbs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: growth rate correlation with MRI parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: morphological parameters correlation based on MRA and CTA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: difference in MRI parameters between patients with and without endoleaks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper and lower extremity function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Happiness Level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Reading Achievement
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Observed Response Rate of Anti-SARS-CoV2 Antibody Seroconversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Infusion rate of propofol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early operative morbidity rate
Endpoint domain: Adverse events/effects
Primary endpoint: Early operative mortality rate
Endpoint domain: Mortality/survival
Primary endpoint: Area Under the plasma concentration time Curve (AUCinf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Annualized rate of change in lesion size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fraction of patients meeting CBCT criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgery-Specific Anxiety Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient's Perception of Nursing Care Scale
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Simplified Functional Movement Disorders Rating Scale (S-FMDRS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Multidimensional Fatigue Inventory Scale (MFI-20) score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Clinical Global Impression (CGI) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability for ART delivery
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Positive COVID-19 Diagnoses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Continuous recovery time of clinical symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Internet Addiction Scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: GPP outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Timed Performance Tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brooke Upper Extremity Functional Classification (BUEFS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vignos Lower Extremity Functional Classification (VAEFS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PedsQL-3.0 Neuromuscular Module by PedsQL Multidimensional Fatigue Scale
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Childhood Depression Rating Scale-Revised
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement Rate from Baseline
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Seroconversion Percentages for the HPV Types 6, 11, 16, 18, 31, 33, 45, 52, and 58
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Participants With at Least 1 Solicited Injection-site Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With at Least 1 Systemic Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With at Least 1 Vaccine-related Serious Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Change in puff topography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Cigarette Evaluation Scale (CES)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hypothetical Purchasing of Tobacco Products
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Eccentric hamstring moment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Hamstring strength endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Alzheimer's Disease Assessment Scale-Cognitive subscale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Regain of bone volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Incidence of toxic events
Endpoint domain: Adverse events/effects
Primary endpoint: Impaired cardiac function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 12-point difference in ASES scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mini-mental State Examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: PSCI Incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Tip-apex distance (TAD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxygen uptake (peak VO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occupational Sitting and Physical Activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Knee Society Rating Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physiological parameters impacting patient outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mRNA and miRNA sequencing of circulating angiogenic cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surface marker expression of inflammatory markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Epigenetic changes in circulating angiogenic cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline of VO2max
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline of Running Economy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline of Maximum aerobic velocity (VAM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of D104N COL18A1 polymorphism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attention assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change In Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Positive and Negative Syndrome Scale (total score, PANSS T)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Device/procedure-related adverse events requiring re-operation or surgical revision
Endpoint domain: Adverse events/effects
Primary endpoint: Final achieved lengthening/distraction (mm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants who used Home HIV Test
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of participants who mailed HIV test
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of participants who checked HIV results
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of HIV positive participants who received HIV treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of HIV negative participants who attended PrEP evaluation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Disease free Survival (DFS) at one year post transplant
Endpoint domain: Mortality/survival
Primary endpoint: Usability using the Pictorial Single-Item Usability Scale (PSIUS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Foot Health Status Questionnaire (FHSQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Success rate of target vessel access
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of patients with difficult spinal anesthesia
Endpoint domain: Adverse events/effects
Primary endpoint: Determination of the exacerbation index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endotoxin core antibody (EndoCab) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Quick Dementia Rating Scale Informant Version & Patient Version (QDRS-IV/PV) Score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from Baseline in Amsterdam Instrumental Activities of Daily Living Questionnaire Short Version (A-IADL-Q-SV) Score
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change from Baseline in Geriatric Depression Scale Short Form (GDS-SF) Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rheumatoid Arthritis Disease Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Usefulness Assessment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Usability Assessment
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Desirability Assessment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Arm circumference measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients carrying BMR and BC germs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Hip Extension Concentric Peak Power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hip Extension Concentric Peak Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in QT interval corrected by Fridericia's formula (QTcF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 1-minute sit-to-stand test (1-MSTST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Participants With Dose Limiting Toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With an Objective Response Rate
Endpoint domain: Physiological/clinical
Primary endpoint: Speech reception threshold (SRT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Migraine days per month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical change of oral mucosa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fluorescence change of oral mucosa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Waveform analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: oral habits (presence / absence)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiac volumetric assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cardiac strain assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Overall Symptom Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Functioning - Social
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Overall Functioning - Role
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Cmax of budesonide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tmax of budesonide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of budesonide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Adverse Events of AQ001S inhalation solution
Endpoint domain: Adverse events/effects
Primary endpoint: Blood pressure (systolic and diastolic) of AQ001S inhalation solution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pulse rate of AQ001S inhalation solution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: hamstring nordic Lower test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: 100 meter sprint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: agility run test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: YMCA sit & reach box
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Clinical cure rate at the test-of-cure visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: All-cause mortality on Day 28
Endpoint domain: Mortality/survival
Primary endpoint: Numeric Pain rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Oswestry index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Prolongation of menstrual period
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Platelet detection in excised brain/medurally tumors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Gastric antral area change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: LPCAT1 genetic polymorphism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Psychomotor Vigilance Test - PVT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Digit-Symbol Substitution Task - DSST
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2-back Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence of adverse events grade 3 or greater
Endpoint domain: Adverse events/effects
Primary endpoint: Influenza transmission rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Soft tissue dimensional changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in reproductive hormone levels after ovarian tissue transplant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Return of regular monthly menstrual cycles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Achievement of successful pregnancy, measured by live birth
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of children with identified enteropathogen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Tumour absorbed dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Optimal biological dose of 161Tb-SibuDAB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of myeloma lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: level of serum osteocalcin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: level of serum sclerostin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Antigen-Specific T-cell Responses in Peripheral Blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Plasma ctDNA detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Contrast clearance analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Functional and structural imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success of intubation for the first time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: myeloperoxidase level in gingival crevicular fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Experiencing Surgical Site Infection (SSI)
Endpoint domain: Adverse events/effects
Primary endpoint: number of colony forming units
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence, type and severity of AEs/SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Analgesics Frequency
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Detection of DSA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Social Responsiveness Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Urine albumin to creatinine ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Percentage of Absolute Oral Bioavailability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Respiratory Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Infants with Observed Head Movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Infants with Observed Arm Movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Olfactory function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline on the Clinical Outcomes in Routine Evaluation (CORE-10) scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from baseline on the Positive and Negative Syndrome Scale for Schizophrenia (PANSS) scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline on the Modified Global Assessment of Functioning - Revised (M-GAF(R)) scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Glucose positive area under the curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevention of hypernatremia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Difficult facemask ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Oral Mucositis Risk Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of patients who remain in the study to trial completion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Successful implantation of Cook Zenith AAA Endovascular Graft
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Difference in Visual analogue scale for total sinus symptom
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in SNOT-22 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in Therapeutic response evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to sustained return of spontaneous circulation (sROSC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feelings of patients
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: AUCt of AJU-C52
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of AJU-C52
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of symptomatic and severe malaria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Restoration of correctly spliced CFTR mRNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Restoration of mature CFTR protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Restoration of CFTR channel function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes